There was a 3-fold increase in all non-coronary artery bypass graft Thrombolysis In Myocardial Infarction ( TIMI ) major bleeding and a 6-fold increase in non-coronary artery bypass graft life-threatening bleeding with pre-treatment with prasugrel ; the same trends persisted in patients who had radial or femoral access even with use of a closure device .